|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng Y and Cullen BR: Sequence
requirements for micro RNA processing and function in human cells.
RNA. 9:112–123. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang LY, Liu M, Li X and Tang H:
miR-490-3p modulates cell growth and epithelial to mesenchymal
transition of hepatocellular carcinoma cells by targeting
endoplasmic reticulum-Golgi intermediate compartment protein 3
(ERGIC3). J Biol Chem. 288:4035–4047. 2013. View Article : Google Scholar :
|
|
6
|
Liang L, Wong CM, Ying Q, et al:
MicroRNA-125b suppresses human liver cancer cell proliferation and
metastasis by directly targeting oncogene LIN28B2. Hepatology.
52:1731–1740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu Q, Liu LZ, Qian X, et al: MiR-145
directly targets p70S6K1 in cancer cells to inhibit tumor growth
and angiogenesis. Nucleic Acids Res. 40:761–774. 2012. View Article : Google Scholar :
|
|
8
|
Gregersen LH, Jacobsen AB, Frankel LB, Wen
J, Krogh A and Lund AH: MicroRNA-145 targets YES and STAT1 in colon
cancer cells. PLoS One. 5:e88362010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li J, Chen Y, Zhao J, Kong F and Zhang Y:
miR-203 reverses chemoresistance in p53-mutated colon cancer cells
through downregulation of Akt2 expression. Cancer Lett. 304:52–59.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nie J, Liu L, Zheng W, et al:
microRNA-365, down-regulated in colon cancer, inhibits cell cycle
progression and promotes apoptosis of colon cancer cells by
probably targeting Cyclin D1 and Bcl-2. Carcinogenesis. 33:220–225.
2012. View Article : Google Scholar
|
|
11
|
Wang CM, Wang Y, Fan CG, et al: miR-29c
targets TNFAIP3, inhibits cell proliferation and induces apoptosis
in hepatitis B virus-related hepatocellular carcinoma. Biochem
Biophys Res Commun. 411:586–592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu SD, Chu CH, Tsou AP, et al: miRNAMap
2.0: genomic maps of microRNAs in metazoan genomes. Nucleic Acids
Res. 36:D165–D169. 2008. View Article : Google Scholar :
|
|
13
|
Peng RQ, Wan HY, Li HF, Liu M, Li X and
Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical
cancer cells by targeting
UDP-N-acetyl-α-D-galactosamine:polypeptide
N-acetylgalactosaminyltransferase 7. J Biol Chem. 287:14301–14309.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shih TC, Tien YJ, Wen CJ, et al:
MicroRNA-214 downregulation contributes to tumor angiogenesis by
inducing secretion of the hepatoma-derived growth factor in human
hepatoma. J Hepatol. 57:584–591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang H, Kong W, He L, et al: MicroRNA
expression profiling in human ovarian cancer: miR-214 induces cell
survival and cisplatin resistance by targeting PTEN. Cancer Res.
68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Zhang Y, Zhang H, et al: miRNA-223
promotes gastric cancer invasion and metastasis by targeting tumor
suppressor EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Penna E, Orso F, Cimino D, et al:
microRNA-214 contributes to melanoma tumour progression through
suppression of TFAP2C. EMBO J. 30:1990–2007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bar-Eli M: Searching for the
‘melano-miRs’: miR-214 drives melanoma metastasis. EMBO J.
30:1880–1881. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duan Q, Wang X, Gong W, et al: ER stress
negatively modulates the expression of the miR-199a/214 cluster to
regulates tumor survival and progression in human hepatocellular
cancer. PLoS One. 7:e315182012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kahn RA, Volpicelli-Daley L, Bowzard B, et
al: Arf family GTPases: roles in membrane traffic and microtubule
dynamics. Biochem Soc Trans. 33:1269–1272. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Beghin A, Honore S, Messana C, et al: ADP
ribosylation factor like 2 (Arl2) protein influences microtubule
dynamics in breast cancer cells. Exp Cell Res. 313:473–485. 2007.
View Article : Google Scholar
|
|
22
|
Wang K, Li P, Dong Y, et al: A
microarray-based approach identifies ADP ribosylation factor-like
protein 2 as a target of microRNA-16. J Biol Chem. 286:9468–9476.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Béghin A, Matera EL, Brunet-Manquat S and
Dumontet C: Expression of Arl2 is associated with p53 localization
and chemosensitivity in a breast cancer cell line. Cell Cycle.
7:3074–3082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng Y, Yi R and Cullen BR: MicroRNAs and
small interfering RNAs can inhibit mRNA expression by similar
mechanisms. Proc Natl Acad Sci USA. 100:9779–9784. 2003. View Article : Google Scholar : PubMed/NCBI
|
